Page
%P
-
Chapter and Conference Paper
Immunomodulation and Therapeutic Effects of a Monotherapy with Interleukin-2 as an Induction Therapy in Patients with Poor-Prognosis Acute Myeloid Leukemia
IL-2 has been shown to induce several mechanisms of MHC-restricted and MHC-unrestricted cytotoxicity against leukemic blasts in vitro and in vivo. Also it is known that patients with AML have a reduced or defe...